Thousands of men could benefit from a new combination of prostate cancer drugs which cut deaths and shrink tumours. Patients given two different pills were three times more likely to experience complete remission than those given only one, a trial found. Thousands of men could benefit from a new combination of prostate cancer drugs which cut deaths and shrink tumours (stock image)And they believe it could improve treatment for more than 10,000 men a year who have advanced prostate cancer with a faulty PTEN gene. All patients had advanced prostate cancer and had received no previous treatment, and half had tumours without a fully-functioning PTEN gene. Professor Paul Workman, chief executive of the ICR, praised the findings, saying the combination could 'extend the time before men's prostate cancer worsens' so that 'they can spend as much time as possible with their loved ones'.

Source: Daily Mail July 08, 2021 23:35 UTC